Empowering innovation: NC’s path to lifesaving individualized treatments
The Right to Try Individualized Treatments Act allows patients suffering from serious or deadly illnesses to seek innovative treatments designed to their unique genetic makeup.
State lawmakers have given unanimous final passage to "Right to Try Individualized Treatments" (House Bill 98). The measure seek to allow patients with terminal or severely debilitating diseases, who have exhausted all other options, to partake in experimental treatments when recommended by a physician.
House Committee discusses 'Right to Try' bill.
Right to Try is gaining momentum across the country, yet states worry a cumbersome federal approval process will continue to inhibit patients’ access to experimental drugs. The Food and Drug Administration allows health-care providers access to experimental drugs and procedures but the process can take months, which frustrates terminally ill patients searching for a cure....
The platform adopted at this week’s Republican National Convention includes a provision urging Congress to enact “Right to Try” legislation, which allows terminally ill patients the opportunity to use drugs or devices that have yet to gain federal Food and Drug Administration approval. The RNC platform, adopted in Cleveland, commends the 31 states, including North Carolina, that...
Advocates of North Carolina’s new “Right to Try” law — and similar ones in other states — are raising awareness of the law, which allows terminally ill patients who have exhausted other procedures the opportunity to try new drugs that gone through part but not all of the Food and Drug Administration’s approval process. “North...